Millie
your market intelligence analyst
Search Results
119 results
Your search is now limited to «Clinical Trials» expert search.
Based on the outcome of the NEW-HOPE trial, Quantum Genomics will initiate a phase 3 pivotal trial in resistant hypertension with Firibastat.
More from Middle East North Africa Financial Network (MENAFN):
GlobeNewswire 10/17/2019 08:30
Additional preclinical data supports the potential use of TSC as a treatment for other conditions where hypoxia plays a major role, such as myocardial infarction, respiratory diseases such as COPD, peripheral artery disease, and neurodegenerative conditions such ...
More from GlobeNewswire:
PR Newswire 10/15/2019 09:35
Cumberland has also completed Phase II clinical programs with ifetroban in patients with Hepatorenal Syndrome ("HRS") and patients with Portal Hypertension ("PH.
More from PR Newswire:
ClinicalTrials.gov 10/14/2019 10:30
Conditions : Coronary Artery Disease; Ischemia; Angina Refractory; Cardiovascular Diseases; Heart Diseases Intervention : Biological: AdVEGFXC1 Sponsor : XyloCor Therapeutics, Inc. Not yet recruiting.
More from ClinicalTrials.gov:
Business Wire 10/10/2019 14:30
Based on these interim results, the Phase 1b protocol has been amended to include patients with ocular hypertension and POAG to further assess safety and activity on IOP in the target patient population.
More from Business Wire:
Pulmonary Hypertension News 10/07/2019 08:00
These positive results support advancing the investigational therapy into Phase 2 studies involving people with pulmonary arterial hypertension (PAH), the treatment’s developer says.
More from Pulmonary Hypertension News:
Noveome has already treated more than 237 patients with ST266 in nine clinical trials in various indications and in all cases, ST266 demonstrated a strong safety profile with no drug related serious adverse events reported.
More from Pharmaceutical Business Review:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications